Tag: Prostate Problems
FDA Approves Gemtesa for Overactive Bladder in Men With BPH
Gemtesa approved for men with overactive bladder symptoms receiving pharmacologic treatment for benign prostatic hyperplasia
Comparable Results Seen for HoLEP With, Without Preservation of Urethral Mucosa in BPH
HoLEP with and without preservation of the urethral mucosa from bladder neck to the tip of the prostate yielded similar efficacy, safety
Prostatic Artery Embolization Offers Lasting Benefit for BPH
PAE is safe and effective for men with lower urinary tract symptoms or acute urinary retention
Surgical Techniques Compared for ThuLEP for Benign Prostatic Hyperplasia
En-bloc and two-lobe techniques may offer efficiency benefits but do not result in improvements in postoperative outcomes
PSA Levels Very Low Among Transgender Women Receiving Estrogen
In a recent study, PSA level was undetectable in 36 percent of transgender women receiving estrogen
Aquablation, HoLEP Provide Unique Benefits for Men With Benign Prostate Hyperplasia
HoLEP has superior operation time, safety profile, and volumetric results
Risk for Benign Prostatic Hyperplasia Increased for Patients With Gout
Hazard ratio for BPH was higher for patients aged younger than 60 years versus those aged 60 years and older
SARS-CoV-2 Infection Linked to Incidence of BPH Complications
Increased incidence seen for urine retention, hematuria, clinical UTI, culture-proven bacteriuria, addition of 5ARI
Minimally Invasive Transperineal Laser Ablation of the Prostate Appears Effective
Findings based on review of literature for treatment of benign prostatic hyperplasia
Optilume BPH Catheter System Provides Sustained Benefits
Immediate and sustained improvement seen in obstructive symptoms and flow rate for men aged 50 years and older with benign prostatic hyperplasia
